US 11959080
Methods and compositions for inhibiting PMP22 expression
granted A61KA61K31/7088A61K9/0019
Quick answer
US patent 11959080 (Methods and compositions for inhibiting PMP22 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/7088, A61K9/0019, A61P, A61P25/02